IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Pharmstandard International S.A.

Q4 2016 Holdings

Filed 2017-02-14 | 4 holdings | $116.1K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Argos Therapeutics Inc.Common040221103$64.9K13,242,27955.9%
Argos Therapeutics Inc.CallCommon040221103$27.4K5,120,60423.6%
Protagonist Therapeutic, Inc.(PTGX)Common74366E102$21.6K983,57018.6%
Proteon Therapeutics Inc.Common74371L109$2.2K1,165,3441.9%